Lymph node yield in pediatric, adolescent and young adult Renal Cell Carcinoma - How many are enough?


Journal

Journal of pediatric surgery
ISSN: 1531-5037
Titre abrégé: J Pediatr Surg
Pays: United States
ID NLM: 0052631

Informations de publication

Date de publication:
Oct 2020
Historique:
received: 16 09 2019
revised: 26 03 2020
accepted: 06 04 2020
pubmed: 16 5 2020
medline: 2 2 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Pediatric, adolescent and young adult (PAYA) patients with renal cell carcinoma (RCC) have a high rate of LN involvement, yet data to guide surgical lymph node (LN) management in this group is limited. The objective is to describe a LN yield threshold to quantify the chance of missing occult LN involvement at ≤10% in PAYAs with RCC. The National Cancer Database was queried for patients aged ≤30 y with unilateral, non-metastaticRCC from 2004 to 2013. The probability of a false negative LN sampling was determined on the cohort of patients who had at least one positive LNand ≥ 2 LNs examined. For a given LN yield, the probability that a positive LN exists but none were found was estimated using a beta-binomial model. We identified 112 patients meeting study criteria. Median age was 24 y and median tumor size was 9.5 cm (IQR 5.8-14). The median number of LNs sampled was 7 (IQR 4-12) and the median number of LNs positive was 4 (IQR 2-7). To achieve ≤10% probability of a false-negativeLN sampling, the beta-binomial model estimated that 5 LNs (95% CI4-7) must be sampled. The desired LN yield to reduce the risk of a false-negativeLN sampling in PAYAs with RCC to ≤10% is 5. This is in keeping with prior studies identifying a LN yield of 6-10 to achieve the same. These data may be used to standardize surgical guidelines when treating PAYAs with renal tumors. II.

Identifiants

pubmed: 32409174
pii: S0022-3468(20)30262-1
doi: 10.1016/j.jpedsurg.2020.04.004
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2030-2034

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Amanda F Saltzman (AF)

Department of Urology, University of Kentucky, Lexington, KY; Department of Surgery, Division of Urology, University of Colorado School of Medicine, Aurora, CO.

Derek E Smith (DE)

Department of Pediatrics, University of Colorado School of Medicine & University of Colorado Cancer Center, Aurora, CO.

Dexiang Gao (D)

Department of Pediatrics, University of Colorado School of Medicine & University of Colorado Cancer Center, Aurora, CO.

Nicholas G Cost (NG)

Department of Surgery, Division of Urology, University of Colorado School of Medicine, Aurora, CO. Electronic address: nicholas.cost@childrenscolorado.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH